These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9462439

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sequential therapy with cefuroxime followed by cefuroxime axetil in community-acquired pneumonia.
    Van den Brande P, Vondra V, Vogel F, Schlaeffer F, Staley H, Holmes C.
    Chest; 1997 Aug; 112(2):406-15. PubMed ID: 9266876
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
    File TM, Segreti J, Dunbar L, Player R, Kohler R, Williams RR, Kojak C, Rubin A.
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
    Shah PM, Maesen FP, Dolmann A, Vetter N, Fiss E, Wesch R.
    J Antimicrob Chemother; 1999 Apr; 43(4):529-39. PubMed ID: 10350383
    [Abstract] [Full Text] [Related]

  • 8. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S.
    Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
    [Abstract] [Full Text] [Related]

  • 9. Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis.
    Langan C, Clecner B, Cazzola CM, Brambilla C, Holmes CY, Staley H.
    Int J Clin Pract; 1998 Oct; 52(5):289-97. PubMed ID: 9796558
    [Abstract] [Full Text] [Related]

  • 10. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis.
    Zervos MJ, Heyder AM, Leroy B.
    J Int Med Res; 2003 Oct; 31(3):157-69. PubMed ID: 12870368
    [Abstract] [Full Text] [Related]

  • 11. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Weiss LR.
    Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
    [Abstract] [Full Text] [Related]

  • 12. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections.
    Brambilla C, Kastanakis S, Knight S, Cunningham K.
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):118-24. PubMed ID: 1396725
    [Abstract] [Full Text] [Related]

  • 13. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Perry CM, Brogden RN.
    Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
    [Abstract] [Full Text] [Related]

  • 14. Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis.
    Wilson R, Langan C, Ball P, Bateman K, Pypstra R, Gemifloxacin 207 Clinical Study Group.
    Respir Med; 2003 Mar; 97(3):242-9. PubMed ID: 12645831
    [Abstract] [Full Text] [Related]

  • 15. Cefuroxime axetil in acute purulent exacerbations of chronic bronchitis.
    Davies BI, Maesen FP, Teengs JP.
    Infection; 1987 Mar; 15(4):253-6. PubMed ID: 3312021
    [Abstract] [Full Text] [Related]

  • 16. Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
    Zuck P, Petitpretz P, Geslin P, Rio Y, Leblanc F.
    Int J Clin Pract; 1999 Sep; 53(6):437-43. PubMed ID: 10622071
    [Abstract] [Full Text] [Related]

  • 17. Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity.
    Davies BI, Maesen FP.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():83-90. PubMed ID: 10404344
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin].
    Kleckow M.
    Fortschr Med; 1991 Jul 30; 109(22):450-4. PubMed ID: 1937326
    [Abstract] [Full Text] [Related]

  • 19. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ, Ormrod D, Goa KL.
    Drugs; 2001 Jul 30; 61(10):1455-500. PubMed ID: 11558834
    [Abstract] [Full Text] [Related]

  • 20. Treatment of otitis media with cefuroxime axetil.
    Aronovitz GH.
    South Med J; 1988 Aug 30; 81(8):978-80. PubMed ID: 3043692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.